Trials / Completed
CompletedNCT00696865
AZD2624 Multiple Ascending Dose Study in Japan
A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2624 When Given in Multiple Ascending Oral Doses in Young Healthy Male Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This multiple ascending dose study will evaluate safety and tolerability after repeated ascending doses of AZD2624
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD2624 | oral suspension, 3 doses |
| DRUG | Placebo |
Timeline
- Start date
- 2008-05-01
- Completion
- 2008-08-01
- First posted
- 2008-06-13
- Last updated
- 2009-07-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00696865. Inclusion in this directory is not an endorsement.